About BioPharmX Corp.

BioPharmX Corp. is a specialty pharmaceutical company focused on developing prescription products utilizing its proprietary HyantX Topical Delivery System for dermatology indications. The HyantX delivery system is designed to stabilize and solubilize hydrophilic molecules in an anhydrous gel environment. The company was founded by James R. Pekarsky and Anja B. Krammer on August 30, 2010 and is headquartered in Campbell, CA.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -0.09$ per share.

The book value per share is 0.02$

BioPharmX Corp. website

Create a solid portfolio with BPMX

Add BPMX to your portfolio and optimize it!


Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- -325.39% -17M - -17M -0.09 - - 171M 0.02 -15M - -15M